RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS

被引：0
|
作者：
Kawaguchi, Yasunori
Otsuka, Taiga
Yoshioka, Wataru
Noge, Shotaro
Takahashi, Hirokazu
Eguchi, Yuichiro
Ozaki, Iwata
Okada, Michiaki
Yanagita, Kimihiko
Kohira, Toshikazu
Ide, Yasushi
Yasutake, Tsutomu
Kawasoe, Hiroaki
Mizuta, Toshihiko
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33701-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1530
引用
收藏
页码：S1099 / S1099
页数：1
相关论文
共 50 条
  • [21] Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection
    Thibault, Vincent
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (03): : 145 - 147
  • [22] Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study
    Takahashi, Hirokazu
    Nakahara, Takashi
    Kogiso, Tomomi
    Imajo, Kento
    Kessoku, Takaomi
    Kawaguchi, Takumi
    Ide, Tatsuya
    Kawanaka, Miwa
    Hyogo, Hideyuki
    Fujii, Hideki
    Ono, Masafumi
    Kamada, Yoshihiro
    Sumida, Yoshio
    Anzai, Keizo
    Shimizu, Masahito
    Torimura, Takuji
    Nakajima, Atsushi
    Tokushige, Katsutoshi
    Chayama, Kazuaki
    Eguchi, Yuichiro
    JGH OPEN, 2021, 5 (02): : 228 - 234
  • [23] Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals
    Joshita, Satoru
    Yamashita, Yuki
    Okamoto, Toru
    Usami, Yoko
    Sugiura, Ayumi
    Yamazaki, Tomoo
    Kakino, Akemi
    Ota, Masao
    Sawamura, Tatsuya
    Umemura, Takeji
    HEPATOLOGY RESEARCH, 2021, 51 (07) : 758 - 766
  • [24] Hepatitis C virus resistance to the new direct-acting antivirals
    Esposito, Isabella
    Trinks, Julieta
    Soriano, Vicente
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1197 - 1209
  • [25] Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)
    Sheridan, David A.
    Neely, R. Dermot G.
    Bassendine, Margaret F.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (01) : 10 - 16
  • [26] Occult Hepatitis B and Risk of Reactivation After Hepatitis C Treatment With Direct-Acting Antivirals
    Ozaras, Resat
    Mete, Bilgul
    Tabak, Fehmi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (04) : 605 - 605
  • [27] Direct-acting antivirals: The answer to hepatitis C virus reactivation after organ transplantation?
    Huang, Hui-Chun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (04) : 319 - 320
  • [28] Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals
    Parlati, Lucia
    Sirmai, Laura
    Dupuy, Claire-Antoinette
    Glotz, Denis
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (02) : E18 - E19
  • [29] Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?
    Maan, Raoel
    Feld, Jordan J.
    GASTROENTEROLOGY, 2017, 153 (04) : 890 - 892
  • [30] Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
    Hsu, Shih-Jer
    Yang, Sheng-Shun
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 3 - 11
12345